General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Drug-specific properties of hypoxia-inducible factor prolyl hydroxylase inhibitors in the treatment of renal anemia

Hypoxic condition is formed in our body when oxygen demand exceeds its supply. It is found elsewhere in our body, and extreme hypoxic condition is formed in diseases such as cancer or ischemia. Our body induces hypoxic response under such conditions to prevent damages. However, hypoxic condition also promotes malignancy of cancers. Hypoxia-Inducible Factor, HIF is a central transcription factor which regulates hypoxic response, however, there are still unknown molecular mechanism regulating the adaptation process to hypoxia. Further, role of hypoxic response in pathophysiological events have also become clearer these days, whereas means to treat hypoxic diseases are still limited. In this symposium, experts in cancer, cardiology, neurons, and metabolism will gather and introduce their own specialties such as tumor model, knockout mice model or imaging. We aim to understand the hypoxic response system, and obtain new ideas for drugs targeting hypoxic responses.

Elucidation of hypoxic response system by multi-disciplinary approaches -aiming to develop new hypoxia-targeting drugs-

APPW2025

Presentation Information

[[OD]2S07a-4]Drug-specific properties of hypoxia-inducible factor prolyl hydroxylase inhibitors in the treatment of renal anemia

Login required to view

Comment